Understanding the Side Effects of Mistletoe Injections in Cancer Support Therapy

 Mistletoe injections, derived from the European mistletoe plant (Viscum album), have gained attention as an integrative therapy in cancer care, particularly in parts of Europe. Companies like ABNOBA GmbH, a research-driven pharmaceutical manufacturer from Germany, are at the forefront of producing standardized mistletoe extracts used in these therapies. While mistletoe injections are often praised for their immune-stimulating and quality-of-life-enhancing effects, understanding their potential side effects is equally important.

Generally, mistletoe therapy is well tolerated. Common side effects are usually mild and may include localized skin reactions at the injection site, such as redness, swelling, or warmth. These are considered signs of the body’s immune response and typically subside on their own. Some patients may experience flu-like symptoms—mild fever, chills, or fatigue—especially during the early phases of treatment.

In rare cases, patients may report allergic reactions such as rash or itching. Serious adverse effects like high fever, difficulty breathing, or severe allergic responses are extremely uncommon but warrant immediate medical attention. The occurrence of side effects often depends on the dosage, frequency of administration, and individual patient sensitivity.

Mistletoe injections should always be administered under medical supervision, particularly when used alongside conventional cancer treatments like chemotherapy or radiation.

At ABNOBA India, patients receive guidance from trained professionals to ensure safe, monitored use of mistletoe therapy. While not a standalone cancer cure, mistletoe offers supportive benefits that can complement standard oncological care when used responsibly.